Enter your login e-mail to the account
Search
Search parameters
Search results
- ROLE OF GENERAL PRACTIONER IN THE TOTAL MANAGEMENT OF LUNG CANCER
doc. MUDr. Peter Beržinec, CSc.
(7-8/2007, Topic ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- The complications of lung cancer diagnostic process
MUDr. Radka Cahajlová, MUDr. Marián Marták
(6/2014, Original articles & case reports ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - PHARMACOECONOMICS OF ONCOLOGIC TREATMENT FORM THE POINT OF VIEW OF HEALTH INSURANCE COMPANY
MUDr. Alexander Paluch, MUDr. Lucia Vitárius, MPH
(1/2008, Review articles ) - SYSTEMIC TREATMENT FOR ADVANCED HEPATOCELLULAR CANCER
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(1/2008, Review articles ) - Milí čitatelia! - úvodné slovo
prof. MUDr. Stanislav Špánik, CSc.
(1/2011, Editorial ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Biological treatment of the small cell lung cancer
MUDr. Peter Kasan
(1/2007, Review articles ) - Biologic and targeted therapy for urogenital maliginities
MUDr. Mária Rečková
(1/2011, Review articles ) - Lung cancer in elderly
doc. MUDr. Mária Wagnerová, CSc.
(1/2007, Review articles ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - Správa z X. Košických chemoterapeutických dní, 23. – 24. november 2006
MUDr. Radovan Barilla
(1/2007, Events ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - 12th Central European Lung Cancer Conference
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Events ) - CURRENT ALTERNATIVES FOR SECOND LINE CHEMOTHERAPY OF RECURRENT CIS-PLATIN REFRACTORY EPITHELIAL OVARIAN CANCER
MUDr. Radovan Barilla
(2/2006, Review articles ) - 10. stredoeurópska konferencia o rakovine pľúc
doc. MUDr. Peter Beržinec, CSc.
(2/2006, Events ) - Liver tumors in childhood – review and the treatment
MUDr. Martina Mikesková, doc. MUDr. Emília Kaiserová, CSc.
(1/2009, Review articles ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Differential diagnostic considerations in medical care of a female patient with duplex malignant tumor
MUDr. Bibiána Krakovská
(4/2007, Original articles ) - Publikujeme v zahraničí
(6/2013, Information & comments ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFRmutant lung cancers
doc. MUDr. Peter Beržinec, CSc.
(6/2013, Information & comments ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - Patient registries – a need for real data in the context of efficacy, safety and cost effectiveness
PharmDr. Dominik Tomek, MPH, RNDr. Mária Pšenková, Ing. Branislav Balvan
(2/2010, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Contemporary possibilities of adrenocortical carcinoma treatment
doc. MUDr. Ján Ľupták, PhD., prof. MUDr. Ján Kliment, CSc., MUDr. Boris Eliáš, PhD., prof. MUDr. Ján Švihra, PhD., MUDr. Ján Kliment jr.
(1/2013, Review articles ) - Clinical significance of PD-L1 immune check-point measurement
MUDr. Peter Kasan
(2/2017, Drugs & drug classes ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Biological therapy in geriatric patients
doc. MUDr. Michal Mego, PhD.
(5/2012, Main topic ) - Metronomic chemotherapy – promising therapeutical approach for recurrent/ refractory high risk tumours in children
MUDr. Irina Oravkinová, MUDr. Ladislav Deák, MUDr. Jaroslava Feketeová, MUDr. Viktória Halušková, MUDr. Ivana Senčáková, MUDr. Igor Jenčo
(5/2011, Original articles & case reports ) - Treatment of advanced metastatic lung cancer in older patients
doc. MUDr. Peter Beržinec, CSc.
(5/2012, Main topic ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - 14. svetová konferencia o karcinóme pľúc v Amsterdame
doc. MUDr. Peter Beržinec, CSc.
(5/2011, Events ) - MEDZINÁRODNÝ KONGRES PROTIRAKOVINOVEJ LIEČBY V PARÍŽI
MUDr. Zuzana Hlavatá
(2/2007, Events ) - Financial expenditures in the context of pharmacotherapy of oncological diseases
doc. PharmDr. Tomáš Tesař, PhD., MBA, PhDr. Ľubica Hlinková, MPH
(1/2014, Main topic ) - Chemotherapy of Tumours of CNS
MUDr. Peter Kalina, CSc.
(3/2010, Review articles ) - Adjuvant therapy of bladder cancer
MUDr. Pavol Dubinský, PhD.
(5/2010, Review articles ) - Treatment of myelodysplastic syndrome with high-risk groups
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(4/2014, Spectrum ) - Systemic treatment of cancer of unknown primary origin
MUDr. Mária Rečková
(4/2013, Main topic ) - Nab-technologies, nab-paclitaxel and new treatment possibilities in the treatment of selected oncology diseases
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(4/2014, Review articles ) - Why do some lung cancer patients receive no anticancer treatment?
doc. MUDr. Peter Beržinec, CSc.
(5/2010, Information & comments ) - Osteoblastic flare effect during targeted therapy in lung adenocarcinoma
MUDr. Gabriela Chowaniecová
(4/2013, Original articles & case reports ) - Pegylated liposomal doxorubicin in the treatment of recurent ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2009, Review articles ) - Chemotherapy of lung cancer – what is new in 2009?
doc. MUDr. Peter Beržinec, CSc.
(1/2010, Review articles ) - Aktuálne z ASCO 2009
doc. MUDr. Peter Beržinec, CSc., prof. MUDr. Stanislav Špánik, CSc., MUDr. Marián Streško
(4/2009, Events ) - A new trend in targeted (biologic) therapy of non-small cell lung cancer in the 2009 – maintenance therapy
MUDr. Peter Kasan
(1/2010, Review articles ) - Systemic treatment of advanced, persistent or recurrent cervical cancer
MUDr. Mária Rečková
(4/2015, Review articles ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Current options and perspectives of both adjuvant and neoadjuvant therapy of cholangiocarcinoma
MUDr. Patrik Palacka, PhD., MUDr. Iveta Vochyanová-Andrezálová
(1/2010, Review articles ) - Antineoplastic treatment of patients with renal insufficency
MUDr. Ján Rajec, PhD., doc. MUDr. Michal Mego, PhD.
(2/2011, Review articles ) - WHAT ARE WE ABLE TO ACHIEVE IN THE TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER TODAY?
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Original articles ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - Systemic therapy of pancreatic cancer
MUDr. Tomáš Šálek, MUDr. Iveta Andrezálová Vochyanová
(3/2012, Main topic ) - Systemic therapy of biliary tract cancers
MUDr. Tomáš Šálek, MUDr. Zuzana Hlavatá, MUDr. Štefan Pörsök, PhD., MUDr. Veronika Švábová, PhD.
(3/2012, Main topic ) - Rare lung cancers
doc. MUDr. Peter Beržinec, CSc.
(2/2013, Main topic ) - RNDr. Gabriel Minárik, PhD.
RNDr. Gabriel Minárik, PhD.
(5/2014, Main topic ) - Targeted terapy of gastric cancer
MUDr. Vanda Ušáková, PhD.
(5/2014, Review articles ) - Správa z podujatia ASCO Chicago 2012
(3/2012, Events ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Crizotinib – a new molecule in the treatment of lung cancer?
MUDr. Lenka Medvecová
(1/2012, Drugs & drug classes ) - SOFT TISSUE SARCOMAS IN CHILDRENS AND ADOLESCENTS
MUDr. Viera Bajčiová, CSc.
(6/2008, Review articles ) - New possibilities and view for treatment of castration resistent prostate cancer
doc. MUDr. Igor Andrašina, CSc., MUDr. Radovan Barilla, PhD.
(1/2012, Review articles ) - Úvodné slovo
MUDr. Radovan Barilla, PhD.
(1/2012, Editorial ) - ODPORÚČANIA SLOVENSKEJ ONKOLOGICKEJ SPOLOČNOSTI SLS PRE ANTIEMETICKÚ LIEČBU V ONKOLÓGII
Slovenská onkologická spoločnosť
(6/2008, Information & comments ) - Current situation in the systemic therapy of liver tumours
MUDr. Tomáš Šálek
(4/2010, Review articles ) - ESMO 2010 – kongres, ktorý prelomil rekordy
doc. MUDr. Peter Beržinec, CSc.
(6/2010, Events ) - Novinky z American Society of Clinical Oncology 2010
doc. MUDr. Peter Beržinec, CSc., MUDr. Tomáš Šálek, prof. MUDr. Stanislav Špánik, CSc., MUDr. Mária Rečková
(4/2010, Events ) - VI. Bardejovské onkologické dni
MUDr. Jozef Chovanec
(4/2010, Events ) - Správa z Best of ASCO® Slovakia 2012
MUDr. Mária Rečková
(6/2012, Events ) - Conservative treatment of rare thoracic tumors – thymoma and carcinoid
MUDr. Mária Černá, CSc.
(6/2011, Review articles ) - Chemotherapy for malignant pleural mesothelioma
doc. MUDr. Peter Beržinec, CSc.
(6/2011, Review articles ) - Pancreatic and biliary cancer
MUDr. Filip Kohútek, PhD., MUDr. Tomáš Sedláček, MUDr. Branislav Bystrický, PhD., MPH
(1/2018, Review articles ) - TREATMENT OF ADULT MALIGNANT BRAIN TUMOURS
MUDr. Peter Kalina, CSc.
(3/2007, Review articles - treatment ) - Nintendanib – new triple inhibitor of angiokinases in 2nd line of NSCLC
MUDr. Zuzana Pribulová
(2/2016, Drugs & drug classes ) - Zaujímavosti z literatúry
doc. MUDr. Peter Beržinec, CSc.
(3/2009, Information & comments ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles ) - 2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
Editor rubriky: doc. MUDr. Peter Beržinec, CSc.
(6/2011, Information & comments )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - NĚKTERÉ POZNATKY Z 66. VÝROČNÍHO MÍTINKU AMERICKÉ DERMATOLOGICKÉ AKADEMIE
doc. MUDr. Karel Ettler, CSc.
(3/2008, Informations ) - SPRÁVA ZO IV. KONGRESU SLOVENSKÝCH A ČESKÝCH DERMATOVENEROLÓGOV S MEDZINÁRODNOU ÚČASŤOU(BRATISLAVA, 5. 6. – 7. 6. 2008)
doc. MUDr. Danka Švecová, PhD.
(2/2008, Informations ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles ) - What is new in knowledge about NMSC
MUDr. Katarína Poláková, PhD.
(4/2012, Review articles )
- Adverse effects and drug interactions of nonsteroidal anti-inflammatory drugs and their management as seen by a pharmacist
Martin Doseděl
(2-3/2014, Current pharmacotherapy )
- Cerebrovascular complications in cancer patients
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. František Horn
(1-2/2012, Review articles )